The Tata CRISIL-IBX Financial Services 3-6 Months Debt Index Fund emerged as September 2026's biggest new fund offer (NFO), raising ₹544 crore according to AMFI data. This debt index fund outperformed all equity schemes, demonstrating strong investor appetite for index-based debt products. The fund's success highlights the growing interest in debt index funds among investors seeking systematic investment approaches.
Among equity offerings, Invesco India Pharma and Healthcare Fund led with ₹403 crore, followed by Bank of India Value Fund at ₹361 crore and The Wealth Company Multi Cap Fund at ₹135 crore. The five equity schemes launched in September collectively raised ₹998 crore. However, this represented a significant decline from August 2026, when equity schemes had mobilised ₹3,051 crore across 26 schemes, indicating a 67% drop in September fundraising.
Index funds emerged as the second-largest category, raising ₹669 crore across six schemes in September 2026. This represented a substantial increase from August's ₹355 crore raised by four index funds. Notable index fund launches included UTI BSE India Sector Leaders Index Fund at ₹39 crore, Axis Nifty500 Low Volatility 50 Index Fund at ₹30 crore, and HDFC BSE REITS and Commercial Real Estate Index Fund at ₹31 crore. The category's performance bucked the overall market trend of declining fund mobilisation.
September 2026 saw 28 new mutual fund schemes collectively raise ₹2,708 crore, compared to August's ₹7,110 crore from 26 schemes. The decline was broad-based across categories, with hybrid schemes falling from ₹1,848 crore to ₹288 crore, debt-oriented schemes dropping from ₹1,647 crore to ₹266 crore, and life cycle funds decreasing from ₹135 crore to ₹135 crore. Exchange-traded funds remained minimal at ₹16 crore from two ETFs, while domestic fund of funds raised ₹336 crore.
